Exploiting and bypassing the bone remodeling cycle to optimize the treatment of osteoporosis.
Dempster
D W
DW
D019386:Alendronate / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D015519:Bone Density / Q000187:drug effects*; D016723:Bone Remodeling / Q000187:drug effects*; D001862:Bone Resorption / Q000188:drug therapy; D005260:Female; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy* / Q000517:prevention & control; D010281:Parathyroid Hormone / Q000494:pharmacology / Q000627:therapeutic use; D012969:Sodium Fluoride / Q000494:pharmacology / Q000627:therapeutic use
D010281:Parathyroid Hormone; D012969:Sodium Fluoride; D019386:Alendronate